Ligand validation:3ECG

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ECG_IMD_B_301	99%	55%	0.057	0.986	0.56	1.16	-	1	0	0	100%	1
3ECG_IMD_A_306	67%	72%	0.105	0.913	0.16	0.89	-	-	3	0	100%	0.5
3ECG_IMD_B_303	55%	79%	0.198	0.967	0.15	0.69	-	-	1	0	100%	0.6
3ECG_IMD_B_302	52%	90%	0.159	0.916	0.23	0.37	-	-	0	0	100%	1
3ECG_IMD_B_305	51%	71%	0.225	0.981	0.08	0.99	-	-	0	0	100%	0.5
3ECG_IMD_A_304	42%	66%	0.185	0.906	0.21	1.08	-	-	0	0	100%	0.5
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	66%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1
6LY4_IMD_A_502	99%	75%	0.059	0.989	0.23	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.